Gilead Sciences Ownership | Who Owns Gilead Sciences?

Overview Forecast RevenueFinancials Chart Transcripts

Gilead Sciences Ownership Summary

Gilead Sciences is owned by 82.84% institutional investors, 0.11% insiders, and 17.05% retail investors. Blackrock is the largest institutional shareholder, holding 9.67% of GILD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.17% of its assets in Gilead Sciences shares.

GILD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Gilead Sciences	82.84%	0.11%	17.05%
Sector	Healthcare Stocks	47.38%	7.99%	44.63%
Industry	Drug Manufacturers - General Stocks	55.65%	0.09%	44.26%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	120.63M	9.67%	$8.28B
Vanguard group	115.26M	9.24%	$7.91B
Capital world investors	76.25M	6.11%	$5.23B
Capital research global investors	60.43M	4.85%	$4.15B
State street	59.33M	4.76%	$4.07B
Dodge & cox	33.12M	2.66%	$2.27B
Geode capital management	26.97M	2.16%	$1.85B
Wellington management group llp	22.94M	1.84%	$1.57B
Morgan stanley	19.34M	1.55%	$1.33B
Fmr	18.48M	1.48%	$1.27B

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sarissa capital management lp	1.10M	12.78%	$75.70M
Sector gamma as	420.16K	10.77%	$28.83M
Cutter capital management, lp	292.96K	6.07%	$20.10M
Mccarthy asset management	130.36K	5.27%	$8.94M
Twin lakes capital management	76.21K	3.57%	$5.23M
F&v capital management	146.21K	2.92%	$10.03M
Sicart associates	110.13K	2.90%	$7.56M
Verity & verity	365.08K	2.73%	$25.05M
Virtus family office	27.41K	2.56%	$1.88M
Rnc capital management	649.42K	2.47%	$44.56M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	17.39M	0.18%	17.39M
Wellington management group llp	22.94M	0.28%	2.37M
Amundi	11.24M	0.29%	1.74M
State street	59.33M	0.18%	1.62M
Ubs asset management americas	11.14M	0.22%	1.61M

Top Sellers

Holder	Shares	% Assets	Change
Capital world investors	76.25M	0.85%	-8.25M
Citadel advisors	278.39K	0.00%	-5.04M
Nuveen asset management	4.99M	0.10%	-3.58M
Voloridge investment management	-	-	-2.38M
Blackrock	120.63M	0.19%	-1.90M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	17.39M	0.18%	17.39M	$1.19B
Mirae asset global etfs	1.06M	0.17%	1.06M	$72.76M
J. safra sarasin	838.14K	1.05%	838.14K	$57.49M
Corebridge financial	391.70K	0.15%	391.70K	$26.87M
Masters capital management	385.00K	1.49%	385.00K	$26.41M

Sold Out

Holder	Change
Cypress capital	-13.00
Tfo-tdc	-15.00
Barrett & company	-16.00
Kelly financial services	-17.00
Indiana trust & investment management	-25.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	1,691	-3.92%	1,032,995,935	1.04%	82	1.23%	759	1.61%	663	-9.80%
Mar 31, 2024	1,760	-3.40%	1,022,412,986	-1.81%	81	1.18%	747	-14.14%	735	6.99%
Dec 31, 2023	1,822	5.44%	1,041,305,648	2.03%	83	1.25%	870	8.34%	687	10.10%
Sep 30, 2023	1,728	-0.86%	1,020,607,071	-1.78%	81	1.18%	803	7.64%	624	-11.86%
Jun 30, 2023	1,743	-2.41%	1,039,056,869	0.23%	83	1.21%	746	-4.97%	708	-1.12%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	39.45M	3.17%	28.77K
Vanguard Institutional 500 Index Trust	32.61M	2.62%	21.51K
American Funds Income Fund of Amer A	31.16M	2.50%	-335.00K
Dodge & Cox Stock I	24.37M	1.96%	-
Invesco QQQ Trust	24.10M	1.94%	-111.94K
Capital Group Wash Mutual Invtrs Comp	22.53M	1.81%	1.50M
American Funds Washington Mutual A	22.53M	1.81%	1.50M
American Funds Capital Income Bldr A	16.05M	1.29%	330.15K
Capital Group American Mutual Comp	15.70M	1.26%	397.06K
American Funds American Mutual A	15.70M	1.26%	397.06K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 06, 2024	Mercier Johanna	Chief Commercial Officer	Sell	$456.40K
Nov 06, 2024	Parsey Merdad	Chief Medical Officer	Sell	$457.50K
Nov 06, 2024	Parsey Merdad	Chief Medical Officer	Sell	$1.88M
Oct 01, 2024	Parsey Merdad	Chief Medical Officer	Sell	$167.66K
Sep 12, 2024	Parsey Merdad	Chief Medical Officer	Sell	$1.80M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	4
2024 Q3	-	6
2024 Q2	-	1
2024 Q1	-	4
2023 Q4	-	1

GILD Ownership FAQ

Who Owns Gilead Sciences?

Gilead Sciences shareholders are primarily institutional investors at 82.84%, followed by 0.11% insiders and 17.05% retail investors. The average institutional ownership in Gilead Sciences's industry, Drug Manufacturers - General Stocks, is 55.65%, which Gilead Sciences exceeds.

Who owns the most shares of Gilead Sciences?

Gilead Sciences’s largest shareholders are Blackrock (120.63M shares, 9.67%), Vanguard group (115.26M shares, 9.24%), and Capital world investors (76.25M shares, 6.11%). Together, they hold 25.03% of Gilead Sciences’s total shares outstanding.

Does Blackrock own Gilead Sciences?

Yes, BlackRock owns 9.67% of Gilead Sciences, totaling 120.63M shares as of Jun 2024. This represents 0.19% of BlackRock's total assets, with a market value of 8.28B$. In the last quarter, BlackRock decreased its holdings by -1.899M shares, a -1.55% change.

Who is Gilead Sciences’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Gilead Sciences’s biggest shareholder by percentage of total assets invested, with 12.78% of its assets in 1.1M Gilead Sciences shares, valued at 75.7M$.

Who is the top mutual fund holder of Gilead Sciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Gilead Sciences shares, with 3.17% of its total shares outstanding invested in 39.45M Gilead Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools